First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient.

Details

Language :

English

Volume :

2

Issue :

1

Database :

Complementary Index

Journal :

EJHaem

Publication Type :

Academic Journal

Accession number :

148592232

Full Text :

https://doi.org/10.1002/jha2.132